Retrospective Multicenter Registry of Coronary Artery Stenting for Acute Myocardial Infarction in Shiga Prefecture

Retrospective Multicenter Registry of Coronary Artery Stenting for Acute Myocardial Infarction in Shiga Prefecture - Shiga AMI registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031941

Enrollment

500

Registered

2018-03-31

Start date

2018-06-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient diagnosed as acute myocardial infarction at the participating centers and received coronary artery stenting from January, 2010 to December, 2012.

Exclusion criteria

Exclusion criteria: 1) Acute myocardial infarction where a condition other than coronary artery disease contributes to an ischemic imbalance (ex. coronary artery spasm, embolization, ischemia due to tachycardia, bradycardia, anemia, respiratory failure, and hypotension). 2) Acute myocardial infarction related to PCI and CABG. 3) Acute myocardial infarction resulting in death when biomarkers are unavailable.

Design outcomes

Primary

Measure	Time frame
Primary endpoint of this study is the composite endpoints of cardiovascular death, myocardial infarction, stroke (ischemic and hemorrhagic), stent thrombosis, and severe bleeding (BARC type2,3,5) at 60-month. The relationship between the primary endpoint and the duration of dual antiplatelet therapy will also be examined.	—

Secondary

Measure	Time frame
1. Composite endpoints of cardiovascular death, myocardial infarction, stroke, definite stent thrombosis, and severe bleeding at 12-month. 2. Mortality rate at discharge, 12-month, and 60-month. 3. Relationship between bleeding / thrombotic score (DAPT score, PRECISE DAPT score, PARIS score) and bleeding / thrombotic event. 4. Relationship between ischemic time (from onset to reperfusion) and the rate of death, cardiovascular death, and heart failure hospitalization at discharge, 12-month and 60-month. 5. Relationship between the presence of residual coronary artery lesion and the rate of death, cardiovascular death, and heart failure hospitalization at discharge, 12-month and 60-month. 6. Relationship between diabetes / dyslipidemia management after discharge and the rate of death, myocardial infarction, stroke, severe bleeding (BARC type2,3,5), and heart failure hospitalization at 60-month.	—

Measure

Time frame

1. Composite endpoints of cardiovascular death, myocardial infarction, stroke, definite stent thrombosis, and severe bleeding at 12-month. 2. Mortality rate at discharge, 12-month, and 60-month. 3. Relationship between bleeding / thrombotic score (DAPT score, PRECISE DAPT score, PARIS score) and bleeding / thrombotic event. 4. Relationship between ischemic time (from onset to reperfusion) and the rate of death, cardiovascular death, and heart failure hospitalization at discharge, 12-month and 60-month. 5. Relationship between the presence of residual coronary artery lesion and the rate of death, cardiovascular death, and heart failure hospitalization at discharge, 12-month and 60-month. 6. Relationship between diabetes / dyslipidemia management after discharge and the rate of death, myocardial infarction, stroke, severe bleeding (BARC type2,3,5), and heart failure hospitalization at 60-month.

—

Countries

Japan

Contacts

Public ContactAkihiro Nishizawa

Koto Memorial Hospital General affairs

subaru@koto-hp.jp0749-45-5000

Outcome results